These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2567175

  • 1. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P, Allegri L, Brianti E, Chatelet F, Van Leer EH, Verroust P.
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [Abstract] [Full Text] [Related]

  • 2. Interaction of antibodies with human glomerular epithelial cells.
    Fukatsu A, Yuzawa Y, Olson L, Miller J, Milgrom M, Zamlauski-Tucker MJ, Van Liew JB, Campagnari A, Niesen N, Patel J.
    Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
    [Abstract] [Full Text] [Related]

  • 3. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G, Brentjens JR, Noble B, Kerjaschki D, Malavasi F, Roholt OA, Farquhar MG, Andres G.
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies to glomerular antigens.
    Ronco P, Sahali D, Cittanova ML, van Leer EH, Chatelet F, Verroust P.
    Nephrol Dial Transplant; 1992 Oct; 7 Suppl 1():9-15. PubMed ID: 1362802
    [No Abstract] [Full Text] [Related]

  • 5. [Formation of immune deposits during experimental extramembranous glomerulonephritis].
    Verroust P, Ronco P.
    Nephrologie; 1989 Oct; 10(3):123-6. PubMed ID: 2691908
    [Abstract] [Full Text] [Related]

  • 6. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
    van Leer EH, Ronco P, Verroust P, de Roo GM, Hoedemaeker PJ, de Heer E.
    Nephrol Dial Transplant; 1992 Oct; 7 Suppl 1():1-8. PubMed ID: 1362800
    [No Abstract] [Full Text] [Related]

  • 7. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.
    Hori MT, Abrass CK.
    J Immunol; 1990 May 15; 144(10):3849-55. PubMed ID: 2185315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G, Noble B, Van Liew J, Brentjens JR, Andres G.
    J Immunol; 1986 Mar 15; 136(6):2127-35. PubMed ID: 3485141
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
    Kerjaschki D, Schulze M, Binder S, Kain R, Ojha PP, Susani M, Horvat R, Baker PJ, Couser WG.
    J Immunol; 1989 Jul 15; 143(2):546-52. PubMed ID: 2738403
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An immunopathologic study of a 330-kD protein defined by monoclonal antibodies and reactive with anti-RTE alpha 5 antibodies and kidney eluates from active Heymann nephritis.
    Ronco P, Neale TJ, Wilson CB, Galceran M, Verroust P.
    J Immunol; 1986 Jan 15; 136(1):125-30. PubMed ID: 2415612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.